Skip to main content
. Author manuscript; available in PMC: 2020 Apr 10.
Published in final edited form as: Leuk Lymphoma. 2017 Jun 2;59(2):274–287. doi: 10.1080/10428194.2017.1330956

Table 1.

HCT-CI [79].

Comorbidity Definition in HCT-CI HCT-CI score
Arrhythmia Atrial fibrillation or flutter, sick sinus syndrome, or ventricular arrhythmias 1
Cardiac Coronary artery disease, congestive heart failure, myocardial infarction, or EF ≤ 50% 1
Gastrointestinal Crohn’s disease or ulcerative colitis 1
Diabetes Requiring insulin or oral hypoglycemic 1
Cerebrovascular disease Transient ischemic attack (TIA) or cerebrovascular accident (CVA) 1
Psychiatric Depression or anxiety requiring psychiatric consult or treatment 1
Hepatic, mild Chronic hepatitis, bilirubin > ULN to 1.5× ULN, or AST/ALT> ULN to 2.5× ULN 1
Obesity Patients with a body mass index (BMI) > 35 kg/m2 1
Infection Requiring continuation of antimicrobial treatment after day 0 1
Rheumatologic SLE, RA, polymyositis, mixed CTD, or PMR 2
Peptic ulcer Requiring treatment 2
Moderate/severe renal Serum creatinine >2 mg/dL, on dialysis, or prior renal transplantation 2
Moderate pulmonary DLCO and/or FEV1 66–88% of dyspnea on slight activity 2
Prior solid tumor Treated at any time point in the patient’s past history, excluding non-melanoma skin cancer 3
Heart valve disease Except mitral valve disease 3
Severe pulmonary DLCO and/or FEV1 ≤ 65% or dyspnea at rest or requiring oxygen 3
Moderate/severe hepatic Liver cirrhosis, bilirubin >1.5× ULN, or AST/ALT >2.5× ULN 3